Skip to main content

DaxibotulinumtoxinA-lanm (Daxxify Brand Toxin Type A) Injection Procedure Code J0589 to Become a Benefit Effective January 1, 2025

Last updated on

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to Medicaid members who are enrolled in their MCO. Administrative procedures, such as prior authorization, precertification, referrals, and claims and encounter data filing, may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the member’s specific MCO for details.

Effective for dates of service on or after January 1, 2025, daxibotulinumtoxinA-lanm (Daxxify brand toxin type A) injection procedure code J0589 will become a benefit of Texas Medicaid when submitted with diagnosis code G243.

For more information, call the TMHP Contact Center at 800-925-9126.